Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Agios Pharmaceuticals Inc
F:8AP
Agios Pharmaceuticals Inc
F:8AP
Price:
29.4
EUR
0.68%
Market Closed
Market Cap:
€1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Agios Pharmaceuticals Inc
F:8AP
|
US |
|
C
|
Cerus Corp
SWB:CU2
|
US |
|
S
|
Saha-Union PCL
SET:SUC
|
TH |
Wall St Price Targets
8AP Price Forecast
Based on 11 analysts
Based on 11 analysts
+90% Upside
from
€29.4
today
Agios Pharmaceuticals Inc (8AP)’s 12-month stock price forecast through October 2027 has a consensus target of €55.91, implying 90% upside. The forecast is based on price targets from 11 Wall Street analysts.
8AP Analyst Rating
No ratings yet
No ratings yet
Agios Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8AP's stock price target?
Price Target
55.91
EUR
55.91
EUR
According to Wall Street analysts, the average 1-year price target for 8AP is 55.91 EUR with a low forecast of 35.43 EUR and a high forecast of 84.03 EUR.
What is the Revenue forecast for Agios Pharmaceuticals Inc?
Projected CAGR
44%
44%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 44%.
What is the Gross Profit forecast for Agios Pharmaceuticals Inc?
Projected CAGR
67%
67%
The compound annual growth rate for Gross Profit over the next 5 years is 67%.